Health care stocks were higher Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each up about 0.8%.
The iShares Biotechnology ETF (IBB) added 0.6%.
In corporate news, Eyenovia (EYEN) shares sank more than 24% after the company reported talks over a potential restructuring.
Aptevo Therapeutics (APVO) shares jumped 6% after the company said the first patient with acute myeloid leukemia dosed in a phase 1b/2 trial evaluating its mipletamig immune-oncology candidate together with standard of care venetoclax and azacitidine achieved a 90% reduction in leukemic blasts within the first 30 days of treatment.
Johnson & Johnson (JNJ) and Merck (MRK) are cutting jobs in China amid growing competition from domestic rivals, Bloomberg reported. Johnson & Johnson shares were down 0.2%, and Merck was adding 0.9%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。